InVivoMAb anti-human Ganglioside GD2 返回列表页

The 14G2a monoclonal antibody reacts with human ganglioside GD2 a sialic-acid bearing glycolipid that is involved in mediating cell attachment to the extracellular matrix. Ganglioside GD2 is expressed on tumors of neuroectodermal origin including human neuroblastoma and melanoma. The tumor specific expression of GD2 makes it a suitable target for immunotherapy with monoclonal antibodies or with artificial T cell receptors. Clone 14G2a is an isotype switch variant selected from the parental IgG3-producing hybridoma 14.18 and has identical reactivity as the parental antibody.

产品名称:InVivoMAb anti-human Ganglioside GD2

反应种属:human

宿主来源:Mouse

实验应用:in vitro induction of apoptosis in GD2+ cells, in vivo inhibition of GD2+ tumor cell growth

同种型:IgG2a, κ

免疫原:Neuroblastoma cell line LAN-1

克隆性:Monoclonal

克隆号:14G2a

产品浓度:Lot specific,typically between 4-11 mg/ml

保存温度:Undiluted at 4°C in the dark

运输温度:Ship with adequate amount of blue ice to ensure the product remains at 4°C for the duration of transit

预期分子量:150 kDa

产品形式:液体

有效期:One year from the date of receipt if stored as recommended

产地:美国

如需购买或咨询Bioxcell公司的产品，请联系Bioxcell*代理商欣博盛生物